CSIMarket
 


Quidel Corporation  (QDEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Quidel's Tangible Leverage Ratio

QDEL's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




QDEL Tangible Leverage Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Tangible Equity Change 587.79 % 716.72 % 1069.15 % 799.48 % 1087.92 %
Y / Y Total Liabilities Change 9.79 % 68.06 % 53.39 % 20.03 % 7.44 %
Tangible Leverage Ratio MRQ 0.41 0.59 0.62 1.04 2.58
Overall Ranking # # # # #
Seq. Tangible Equity Change -6.95 % 18.7 % 127.42 % 173.81 % 10.5 %
Seq. Total Liabilities Change -34.74 % 12.85 % 34.58 % 10.77 % -0.1 %



Tangible Leverage Ratio second quarter 2021 Comment
Due to repayements of liabilities of -34.74% Quidel improved Tangible Leverage Ratio in second quarter 2021 to 0.41, below company's average Tangible Leverage Ratio.

Within Biotechnology & Drugs industry in the second quarter 2021, 95 other companies have achieved lower Tangible Leverage Ratio than Quidel. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is QDEL Market Share?
Tangible Leverage Ratio second quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 96
Healthcare Sector # 348
Overall Market # 769


Tangible Leverage Ratio Statistics
High Average Low
2.34 0.63 0.15
(Dec 31 2017)   (Mar 31 2013)




Financial Statements
Quidel's Tangible Equity $ 965 Millions Visit QDEL's Balance sheet
Quidel's Total Liabilities $ 397 Millions Visit QDEL's Balance sheet
Source of QDEL's Sales Visit QDEL's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingJun 30 2021, within Biotechnology & Drugs Industry Tangible Leverage RatioJun 30 2021 MRQ Total LiabilitiesJun 30 2021 MRQ Tangible Equity
Sangamo Therapeutics Inc   1.12 $ 389.906  Millions$ 347.658  Millions
Adma Biologics Inc   1.07 $ 113.618  Millions$ 105.978  Millions
Unity Biotechnology Inc   1.07 $ 70.346  Millions$ 65.917  Millions
Royalty Pharma Plc  1.04 $ 10,781.234  Millions$ 10,388.103  Millions
Brooklyn Immunotherapeutics Inc   1.03 $ 26.997  Millions$ 26.279  Millions
Navidea Biopharmaceuticals Inc   0.97 $ 5.576  Millions$ 5.732  Millions
Gossamer Bio Inc   0.96 $ 211.817  Millions$ 220.693  Millions
Meridian Bioscience Inc   0.96 $ 124.414  Millions$ 130.097  Millions
Iterum Therapeutics Plc  0.92 $ 43.345  Millions$ 47.195  Millions
Soligenix inc   0.89 $ 13.900  Millions$ 15.596  Millions
Champions Oncology Inc   0.78 $ 5.583  Millions$ 7.203  Millions
Integrated Biopharma Inc  0.77 $ 11.106  Millions$ 14.334  Millions
Merus N v   0.74 $ 160.496  Millions$ 216.479  Millions
Axcella Health Inc   0.69 $ 33.397  Millions$ 48.087  Millions
Curis Inc   0.66 $ 68.087  Millions$ 103.492  Millions
Regenxbio Inc   0.65 $ 329.157  Millions$ 507.245  Millions
Nanovibronix Inc  0.64 $ 2.658  Millions$ 4.164  Millions
Cannabics Pharmaceuticals Inc   0.63 $ 1.470  Millions$ 2.332  Millions
Beam Therapeutics Inc   0.63 $ 344.527  Millions$ 548.551  Millions
Pluristem Therapeutics Inc  0.62 $ 35.653  Millions$ 57.151  Millions
Phathom Pharmaceuticals Inc   0.61 $ 81.076  Millions$ 132.128  Millions
Cyanotech Corp  0.60 $ 10.503  Millions$ 17.579  Millions
Repligen Corp  0.58 $ 408.653  Millions$ 708.927  Millions
Chromadex Corporation  0.58 $ 23.700  Millions$ 41.181  Millions
Akoya Biosciences Inc   0.54 $ 58.521  Millions$ 107.915  Millions
Neurocrine Biosciences Inc   0.53 $ 677.200  Millions$ 1,279.200  Millions
Voyager Therapeutics Inc   0.53 $ 58.466  Millions$ 110.536  Millions
Zymeworks Inc   0.52 $ 150.482  Millions$ 288.665  Millions
Heska Corporation  0.50 $ 145.600  Millions$ 290.097  Millions
Bluebird Bio Inc   0.49 $ 469.898  Millions$ 955.170  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OCAX's Profile

Stock Price

OCAX's Financials

Business Description

Fundamentals

Charts & Quotes

OCAX's News

Suppliers

OCAX's Competitors

Customers & Markets

Economic Indicators

OCAX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071